Karl Blom

Karl Anders Blom currently works at Peptonic Medical AB, as Chairman from 2023, Rosland Nordic AB, as Chairman from 2017, Alzinova AB, as Independent Director from 2021, Challengehop, Inc., as Director, Hunterhex International Ltd., as Director, Wonderboo Holding AB, as Independent Director from 2022, Wonderboo AB, as Director from 2019, Hunterhex AB, as Director from 2018, Terranet Tech AB, as Director from 2022, and Petslovesurprises AB, as Director from 2023.
Mr. Blom also formerly worked at Nexttobe AB, as Chief Executive Officer from 2011 to 2015, Maida Vale Capital AB, as Chairman, Black T Quant AB, as Chairman from 2019 to 2022, Hansa Biopharma AB, as Independent Director from 2014 to 2016, BioLamina AB, as Director, The Delta Projects AB, as Director, Selego AB, as Director, Terranet AB, as Independent Director from 2022 to 2026, Globopetz AB, as Independent Director, Qdoxx Pharma AB, as Director from 2016 to 2019, Oasmia Incentive AB, as Director from 2016 to 2019, Evolutience Pharmaceutical AB, as Director from 2020 to 2022, Skatteverket, as Auditor, Q-Med AB, as Controller, Head-Business & Corporate Development from 2001 to 2005, Pharmacia AB, as Business Controller from 1997 to 2001, and Vivesto AB, as Chief Financial Officer & Executive Vice President from 2017 to 2019.
Mr. Blom received his undergraduate degree and Masters Business Admin degree from the University of Uppsala.